Antitumor effect of mSurvivinThr34→Ala in murine colon carcinoma when administered intravenously (Q43233318)

16 November 2017

title

Antitumor effect of mSurvivinThr34→Ala in murine colon carcinoma when administered intravenously (English)

1 reference

16 November 2017

1 reference

Hong-xia Li

1

1 reference

16 November 2017

Xin-yu Zhao

2

1 reference

16 November 2017

Lian Wang

3

1 reference

16 November 2017

Yong-sheng Wang

4

1 reference

16 November 2017

Bin Kan

5

1 reference

16 November 2017

Jian-rong Xu

6

1 reference

16 November 2017

Jiong Li

7

1 reference

16 November 2017

Yan-Jun Wen

8

1 reference

16 November 2017

Xing-chen Peng

9

1 reference

16 November 2017

Xiang Chen

10

1 reference

16 November 2017

Fei Yan

11

1 reference

16 November 2017

Bin Ye

12

1 reference

16 November 2017

Xiao-bo Du

13

1 reference

16 November 2017

Ju-mei Zhao

14

1 reference

16 November 2017

Tao Yi

15

1 reference

16 November 2017

Xian-cheng Chen

16

1 reference

16 November 2017

Xiao-xia Du

17

1 reference

16 November 2017

Yu-quan Wei

18

1 reference

16 November 2017

Xia Zhao

19

1 reference

16 November 2017

publication date

1 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

27

1 reference

16 November 2017

issue

4

1 reference

16 November 2017

page(s)

1156-1163

1 reference

Cancer gene therapy using a survivin mutant adenovirus

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9353-2

Control of apoptosis during angiogenesis by survivin expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9353-2

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9353-2

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9353-2

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9353-2

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells

21 January 2018

1 reference

12 December 2020

Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells

1 reference

12 December 2020

Establishment of mouse colonic carcinoma cell lines with different metastatic properties

1 reference

12 December 2020

CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer

1 reference

12 December 2020

Identification of dying cells--in situ staining

1 reference

12 December 2020

1 reference

12 December 2020

In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

1 reference

12 December 2020

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

1 reference

12 December 2020

Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ

1 reference

12 December 2020

Cytolysis by Ca-permeable transmembrane channels. Pore formation causes extensive DNA degradation and cell lysis

1 reference

12 December 2020

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

1 reference

12 December 2020

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

1 reference

12 December 2020

An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene

1 reference

12 December 2020

Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant

1 reference

12 December 2020

Non-viral gene delivery systems

1 reference

12 December 2020

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

12 December 2020

Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells

1 reference

12 December 2020

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

1 reference

12 December 2020

BIRinging chromosomes through cell division--and survivin' the experience

1 reference

12 December 2020

Analysis of regulatory CD8 T cells in Qa-1-deficient mice

1 reference

12 December 2020

Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors

1 reference

12 December 2020

Full-length dominant-negative survivin for cancer immunotherapy.

1 reference

12 December 2020

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

1 reference

12 December 2020

Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway

1 reference

12 December 2020

Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype

1 reference

12 December 2020

Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy

1 reference

12 December 2020

Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients

1 reference

12 December 2020

Improved DNA: liposome complexes for increased systemic delivery and gene expression

1 reference

12 December 2020

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis

1 reference

12 December 2020

Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis

1 reference

12 December 2020

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

1 reference

12 December 2020

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

12 December 2020

The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients

1 reference

12 December 2020

Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis

1 reference

12 December 2020

Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic

1 reference

12 December 2020

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

12 December 2020

The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens

1 reference

12 December 2020

Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis

1 reference

12 December 2020

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

1 reference

12 December 2020

Increase of regulatory T cells in the peripheral blood of cancer patients.

1 reference

12 December 2020

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer

1 reference

12 December 2020

Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas

1 reference

12 December 2020

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

1 reference

12 December 2020

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

1 reference

12 December 2020

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

1 reference

12 December 2020

Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides

1 reference

12 December 2020

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

1 reference

12 December 2020

Expression of survivin in gastric cancer and its relationship with tumor angiogenesis

1 reference

12 December 2020

Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta

1 reference

12 December 2020

10.1007/S12032-009-9353-2

Identifiers

DOI

1 reference

Dimensions Publication ID

16 November 2017

1011599200

0 references

1 reference